Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data
2014 Standout
Circular RNA ciRS-7—A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer
2017
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
2007
Clinical utility of RASSF1A methylation in human malignancies
2015
Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma
2012
TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
2009
The DNA-damage response in human biology and disease
2009 StandoutNature
Base-excision repair of oxidative DNA damage
2007 StandoutNature
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
2015
Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer
2004
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Parkinson's disease
2021 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
2013 Standout
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
2017
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
2014
Tumorigenic Cells Are Common in Mouse MPNSTs but Their Frequency Depends upon Tumor Genotype and Assay Conditions
2012
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
2012
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
2018 StandoutNobel
Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma
2008
The Human Transcription Factors
2018 Standout
Emerging roles of proteases in tumour suppression
2007
The ETS family of oncogenic transcription factors in solid tumours
2017
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cancer stem cells revisited
2017 Standout
A 19-Gene expression signature as a predictor of survival in colorectal cancer
2016
Colorectal cancer
2013 Standout
Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study
2012 Standout
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
DNA damage response in human testes and testicular germ cell tumours: biology and implications for therapy
2007
Epigenetics in Cancer
2008 Standout
Candidate Genes for Testicular Cancer Evaluated by In Situ Protein Expression Analyses on Tissue Microarrays
2003
The Hippo Signaling Pathway in Development and Cancer
2010 Standout
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
2006
Testicular germ-cell tumours in a broader perspective
2005 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Chromosomes, genes, and development of testicular germ cell tumors
2004
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
2007
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
The many ways of Wnt in cancer
2007
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas
2013
The biogenesis, biology and characterization of circular RNAs
2019 Standout
The Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing
2015
Clonal evolution in cancer
2012 StandoutNature
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Colorectal Cancer: Molecular Mutations and Polymorphisms
2013
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
The PI3K Pathway in Human Disease
2017 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Galectin expression in cancer diagnosis and prognosis: A systematic review
2015
The associations between Parkinson’s disease and cancer: the plot thickens
2015
Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity
2014
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Role of YAP/TAZ in mechanotransduction
2011 StandoutNature
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Primary sclerosing cholangitis – a comprehensive review
2017
Update on primary sclerosing cholangitis
2013
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Whole‐genome methylation analysis of benign and malignant colorectal tumours
2012
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
Bidirectional regulation between TMEFF2 and STAT3 may contribute to H elicobacter pylori‐associated gastric carcinogenesis
2014
Molecular Genetics of Colorectal Cancer
2011
Repair and Genetic Consequences of Endogenous DNA Base Damage in Mammalian Cells
2004 StandoutNobel
Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
2015
Cancer Genome Landscapes
2013 StandoutScience
Microsatellite instability in colorectal cancer
2006
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer
2014
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Bromodomain and Extra-Terminal Motif Inhibitors: a Review of Preclinical and Clinical Advances in Cancer Therapy
2019
Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects
2006
Identification of molecular apocrine breast tumours by microarray analysis
2005
MiR‐182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene
2017
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Works of Guro E. Lind being referenced
Three Epigenetic Biomarkers, GDF15 , TMEFF2 , and VIM , Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
2010
Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development
2005
MiR-9, -31, and -182 Deregulation Promote Proliferation and Tumor Cell Survival in Colon Cancer
2012
Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
2017
A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
2004
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
2007
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
2002
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome
2011
The exon‐level biomarker SLC39A14 has organ‐confined cancer‐specificity in colorectal cancer
2011
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis
2014
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
2012
Epigenetic and genetic features of 24 colon cancer cell lines
2013
Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
2011
ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis
2006
Mutation Screening of the TP53 Gene by Temporal Temperature Gel Electrophoresis (TTGE)
2014
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
2008
Primary sclerosing cholangitis and malignancy
2011
Mutation Screening of the <I>TP53</I> Gene by Temporal Temperature Gradient Gel Electrophoresis
2004
Expression Patterns of Cell Cycle Components in Sporadic and Neurofibromatosis Type 1-Related Malignant Peripheral Nerve Sheath Tumors
2005
Genetic and Epigenetic Changes of Components Affecting the WNT Pathway in Colorectal Carcinomas Stratified by Microsatellite Instability
2005
Novel Genomic Aberrations in Testicular Germ Cell Tumors by Array‐CGH, and Associated Gene Expression Changes
2006
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
2013
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes
2013
Novel mutations of the suppressor genePTENin colorectal carcinomas stratified by microsatellite instability- andTP53mutation- status
2008
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
2011
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
2007
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
2012
Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin
2010
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
2017